AutoAsmaAlert: Technological tool to prevent Salbutamol Overuse in a Colombian Healthcare Provider "Letter to the Editor"
DOI:
https://doi.org/10.53713/htechj.v2i3.192Keywords:
SABA, salbutamol, overuse, asthma, Auto Asthma AlertsAbstract
The use of Salbutamol for the treatment of asthma has been a part of regular therapy as a short-acting β2-agonist since the 1960s. In the GINA 2024 guidelines, it is indicated that the use of salbutamol in monotherapy has been associated with increased mortality and poor asthma control. Therefore, the development of alternatives that allow rapid identification of its overuse is of great interest for the management of the disease. In order to achieve this objective, it was proposed to develop the technological tool, Auto Asthma Alerts “AAA”, with the aim to identifying in the clinical history and in real time the overuse of SABA (more than 3 inhalers per year) and thus alert physicians. The platform was successfully trialled on a pilot scale in a healthcare institution in Montería, Colombia, MediSinu IPS.
References
Medinaceli Díaz, K. I., Martin, M., & Choque, S. (2021). Impacto y regulación de la Inteligencia Artificial en el ámbito sanitario. REVISTA IUS, 15(48). https://doi.org/10.35487/RIUS.V15I48.2021.745
Nwaru, B. I., Ekström, M., Hasvold, P., Wiklund, F., Telg, G., & Janson, C. (2020). Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. European Respiratory Journal, 55(4). https://doi.org/10.1183/13993003.01872-2019
Pedrozo-Pupo, J. C., Gallego, M. C. P., Álvarez, I. de J. B., Raad, R. A. J., Pinilla, A. C. C., Londoño, H. R., Villada, L. B., & Beekman, M. (2022). A Cross-Sectional Study on Prescription Patterns of Short-Acting β2-Agonists in Patients with Asthma: Results from the SABINA III Colombia Cohort. Journal of Asthma and Allergy, 15, 1167–1178. https://doi.org/10.2147/JAA.S365009
Plaza Zamora, F., Moranta Ribas, F., Sánchez Marcos, N., Mendoza Barbero, A., Gaztelurrutia Lavesa, L., & Deleito Molina, O. (2022). Descripción de la herramienta de sobreuso de salbutamol en SEFAC e_XPERT. Farm. Comunitarios (Internet), 14, 1–1. https://doi.org/10.33620/FC.2173-9218.(2022).CMC.247
Reddel, H. K., Arzu, Y., & Chair, GINA Science Committe Chair, G. B. of D. (2024). 2024 GINA Report, Global Strategy for Asthma Management and Prevention (pp. 1–261). https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Main-Report-WMS-1.pdf
van den Berg, L. N., Hallensleben, C., Chavannes, N. H., & Versluis, A. (2022). Developing a Smartphone Application That Promotes Responsible Short-Acting Beta2-Agonist Use in People with Asthma: A Participatory Design. International Journal of Environmental Research and Public Health, 19(14), 8496. https://doi.org/10.3390/IJERPH19148496
